Head-To-Head Comparison: OpGen (OPGN) and Aeon Global Health (AGHC)

OpGen (NASDAQ:OPGN) and Aeon Global Health (OTCMKTS:AGHC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation and dividends.

Analyst Ratings

This is a breakdown of recent ratings and target prices for OpGen and Aeon Global Health, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OpGen 0 0 1 0 3.00
Aeon Global Health 0 0 1 0 3.00

OpGen currently has a consensus target price of $6.00, indicating a potential upside of 246.82%. Given OpGen’s higher possible upside, analysts plainly believe OpGen is more favorable than Aeon Global Health.

Institutional & Insider Ownership

4.1% of OpGen shares are held by institutional investors. 7.1% of OpGen shares are held by company insiders. Comparatively, 11.5% of Aeon Global Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares OpGen and Aeon Global Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OpGen -395.63% -238.35% -118.17%
Aeon Global Health -43.06% -337.28% -61.42%

Risk & Volatility

OpGen has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Aeon Global Health has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500.

Earnings & Valuation

This table compares OpGen and Aeon Global Health’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OpGen $3.21 million 4.66 -$15.41 million ($9.78) -0.18
Aeon Global Health $16.30 million 0.19 -$8.00 million ($1.15) -0.37

Aeon Global Health has higher revenue and earnings than OpGen. Aeon Global Health is trading at a lower price-to-earnings ratio than OpGen, indicating that it is currently the more affordable of the two stocks.

Summary

Aeon Global Health beats OpGen on 7 of the 12 factors compared between the two stocks.

About OpGen

OpGen, Inc., a precision medicine company, engages in developing molecular information products and services to combat infectious diseases in the healthcare industry worldwide. The company utilizes molecular diagnostics and bioinformatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Panel in vitro diagnostic test designed to detect bacterial nucleic acids; and QuickFISH and PNA FISH products, which are FDA-cleared and CE-marked diagnostic test designed to detect antimicrobial- resistant pathogens. It also provides Acuitas MDRO Gene Test, Acuitas CR Elite Test, and Acuitas Resistome Test that are CLIA lab-based tests, which provide a profile of MDRO resistant genes for surveillance and response to outbreaks. In addition, the company offers Acuitas Lighthouse bioinformatics systems, which are cloud-based HIPAA compliant bioinformatics offerings that combine clinical lab test results with patient and hospital information, and provide analytics to enable manage MDROs in the hospital and patient care environment. Further, it engages in the development of Acuitas Rapid Test designed to detect urinary tract infection. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.

About Aeon Global Health

Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. The company operates through Laboratory Testing Services and Web-Based Software segments. Its laboratory testing services include the testing of an individual's blood, urine, or saliva for the presence of drugs or chemicals, as well as the patient's DNA profile. The company primarily offers medical toxicology, DNA pharmacogenomics, cancer genetic testing, and molecular biology tests. It also provides Web-based services as software as a service for Web-based revenue cycle management applications; and telehealth products and services that enable healthcare organizations to coordinate care for patients, and enhance related administrative and clinical workflows, as well as compliance with regulatory requirements. In addition, AEON Global Health Corp. offers post contract customer support services. The company was formerly known as Authentidate Holding Corp. and changed its name to Aeon Global Health Corp. in January 2018. Aeon Global Health Corp. is headquartered in Gainesville, Georgia.

Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply